By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


United Therapeutics Corporation 

1110 Spring Street

Silver Spring  Maryland  20910  U.S.A.
Phone: 301-608-9292 Fax: 301-608-9291



Company News
United Therapeutics (UTHR) Announces Settlement Of Patent Litigation With Sandoz 9/30/2015 6:59:41 AM
Synthetic Genomics, Inc. Expands Collaborative Research And Development Agreement With Lung Biotechnology PBC, A Subsidiary Of United Therapeutics (UTHR), To Develop Organs For Transplantation 9/23/2015 11:21:46 AM
AbbVie (ABBV) Forks Over $350 Million Cash to United Therapeutics (UTHR) for Rare Pediatric Disease Priority Voucher 8/19/2015 6:18:43 AM
United Therapeutics Corporation (UTHR) Release: European Commission (EC) Grants Marketing Authorisation For Unituxin (dinutuximab) For The Treatment Of Paediatric High-Risk Neuroblastoma 8/17/2015 6:49:20 AM
United Therapeutics Corporation (UTHR) To Present At The 2015 Wedbush PacGrow Healthcare Conference 8/6/2015 1:34:36 PM
United Therapeutics Corporation (UTHR) Reports Second Quarter 2015 Financial Results 7/28/2015 12:45:45 PM
United Therapeutics Corporation (UTHR) To Announce Second Quarter 2015 Financial Results Before Market Open On Tuesday, July 28, 2015 7/22/2015 11:38:31 AM
Dean Judy D. Olian Joins The United Therapeutics Corporation (UTHR) Board Of Directors 6/29/2015 7:34:35 AM
United Therapeutics Corporation (UTHR) Receives Paragraph IV Notice Letter For Tyvaso 6/15/2015 7:48:05 AM
United Therapeutics Corporation (UTHR) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/29/2015 7:42:21 AM